Published in Gene Therapy Weekly, September 8th, 1997
The clinical trial is being conducted at Johns Hopkins medical institutions, Baltimore, Maryland. The IL-2 Cancer Gene Medicine is the first product to result from the corporate alliance Genemedicine formed with Boehringer Mannheim in July 1995. An additional Phase I human clinical trial to be conducted in Germany in collaboration with Boehringer Mannheim is expected to begin in the next few weeks.
"This marks the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.